Investment in biotech is booming. In Europe, the biotechnology and healthcare sector accounted for 20% of overall private equity investment in the first half of 2020, according to data from funds trade body Invest Europe.
Donia Rouigueb, head of sales for securities finance and repo at CACEIS, participated in our recent securities finance roundtable. She reflects on whether asset owners are likely to move their sec lending activity in-house and on broader issues, including steps to standardise market practice.
Asset owners, managers and consultants examine the use of intelligence to pursue ESG, climate and financial goals at the same time, intermediary targets as a vehicle to meeting long-term goals and diversity in all its forms. Chaired by Romil Patel.
DWS’s stake in Arabesque showed how asset management is moving towards AI-powered investing. Alex Rolandi talks to Arabesque and other AI players, such as Aberdeen Standard Investments, about heading for tomorrow’s world.